Louisiana 2020 2nd Special Session

Louisiana House Bill HB101

Introduced
10/21/20  
Introduced
10/21/20  

Caption

Provides relative to reimbursement rates for certain ventilation treatments (Items #28 and #40)

Impact

The enactment of HB 101 will have a significant impact on health insurance policies within the state. By removing reimbursement caps for non-invasive ventilation treatments, the bill will likely lead to greater access to care for patients, as they will not have to worry about insurance limits affecting their treatment options. This shift aims to improve patient outcomes and ensure that necessary treatments are provided in accordance with medical recommendations without the constraint of financial barriers from insurance companies.

Summary

House Bill 101, sponsored by Representative Dustin Miller, aims to protect patients receiving non-invasive ventilation treatments by prohibiting insurers, managed care companies, or other payors from setting a maximum reimbursement cap for these services. The legislation seeks to ensure that individuals can access necessary medical treatment without facing financial limitations imposed by insurance providers. This change in policy is crucial for patients who require these types of treatments, which can be essential for their health and well-being.

Sentiment

The sentiment around HB 101 is generally positive among healthcare advocates and patient rights groups, as they believe the bill addresses a critical need for fair access to necessary medical treatments. Supporters applaud the bill for prioritizing patient care over insurance profitability, highlighting its potential to improve health outcomes. However, concerns may arise from some insurance providers about the financial implications of uncapped reimbursements, as this could affect their operational costs and pricing structures.

Contention

Notable points of contention surrounding HB 101 may revolve around the balance between patient access to care and the financial viability for insurers. While the bill clearly aims to enhance patient protections, there is apprehension regarding how insurers will manage increased costs associated with unlimited reimbursements for non-invasive ventilation treatments. Stakeholders in the healthcare industry may debate the sustainability of such mandates and the potential pressures it could place on insurance markets and healthcare pricing.

Companion Bills

No companion bills found.

Previously Filed As

LA HB594

Provides relative to reimbursement rates for certain ventilation treatments

LA SB2224

Commissioner of Insurance; authorize to adopt rules and regulations regarding certain provider reimbursement rates.

LA HB658

Medicaid; delete freeze on provider reimbursement rates and establish procedure for review of proposed rate changes.

LA HB390

Relative to reimbursement rates paid to providers of disability services (EN NO IMPACT See Note)

LA HB657

Medicaid; delete freeze on provider reimbursement rates and make various technical amendments to services section.

LA HB468

Provides relative to utilization review standards and approval procedures for healthcare service claims submitted by healthcare providers (EN NO IMPACT See Note)

LA HB436

Provides for insurance reimbursement of certain provider fees paid by pharmacies (EN SEE FISC NOTE GF EX See Note)

LA SB262

Provides relative to patient and provider access to care. (gov sig)

LA HB9

Provides for sales and use tax on certain services (Items #8 and 13) (EG +$492,000,000 RV See Note)

LA HB94

Provides relative to reimbursement for implants

Similar Bills

No similar bills found.